Benzinga's Top Upgrades - Citigroup (NYSE:C)

Analysts at Credit Suisse upgraded PTC Therapeutics, Inc. PTCT from Neutral to Outperform. The price target for PTC Therapeutics has been raised from $15 to $25. PTC Therapeutics shares rose 8.41 percent to $12.25 in pre-market trading.
KeyBanc upgraded Square Inc SQ from Sector Weight to Overweight. Square shares rose 1.60 percent to $12.07 in pre-market trading.
Morgan Stanley upgraded Citigroup Inc C from Equal-Weight to Overweight. Citigroup shares gained 0.45 percent to $53.07 in pre-market trading.
Analysts at Baird upgraded Actuant Corporation ATU from Neutral to Outperform. Actuant shares rose 1.97 percent to $25.90 in pre-market trading.
Citigroup upgraded Kohl's Corporation KSS from Neutral to Buy. Kohl's shares gained 4.41 percent to close at $53.22 on Friday.
Analysts at Stifel Nicolaus upgraded GrubHub Inc GRUB from Hold to Buy. GrubHub shares fell 4.82 percent to close at $35.31 on Friday.
Bernstein upgraded Centene Corp CNC from Market Perform to Outperform. Centene shares gained 2.60 percent to $52.00 in pre-market trading.
Analysts at UBS upgraded Quest Diagnostics Inc DGX from Neutral to Buy. Quest shares rose 0.75 percent to $82.07 in pre-market trading.
Bank of America upgraded Credit Suisse Group AG (ADR) CS from Neutral to Buy. Credit Suisse shares rose 0.91 percent to $14.35 in pre-market trading.
Analysts at Stifel Nicolaus upgraded Lockheed Martin Corporation LMT from Hold to Buy. The price target for Lockheed Martin has been raised from $260 to $290. Lockheed Martin shares closed at $5.45 on Friday.

Market News and Data brought to you by Benzinga APIs